V. Bonfante - Concepedia

Author

V. Bonfante

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

V Bonfante, V. Bonfante, VALERIA BONFANTE, Valeria Bonfante

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Fondazione Humanitas per la Ricerca University of Verona The University of Texas MD Anderson Cancer Center National and Kapodistrian University of Athens

About

V. Bonfante is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.9K
2	Health Sciences	9	9	306
3	Natural Sciences	2	2	78
4	Cellular Therapies	2	2	60
5	Biochemistry	1	1	31

V. Bonfante

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi, New England Journal of Medicine	2011	419
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. Armando Santoro, Gianni Bonadonna, Pinuccia Valagussa, Journal of Clinical Oncology PathologyPharmacotherapyMetronomic ChemotherapyHematological MalignancyRadiation Medicine	1987	380
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD Simonetta Viviani, Armando Santoro, G. Ragni, European Journal of Cancer and Clinical Oncology Comparative ResultsCombination ChemotherapyMedicineMetronomic TherapyGynecology	1985	370
ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term Results Gianni Bonadonna, V. Bonfante, Simonetta Viviani, Journal of Clinical Oncology	2004	336
Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease Armando Santoro, V. Bonfante, Gianni Bonadonna Annals of Internal Medicine Salvage ChemotherapyAdvanced Recurrent HodgkinMedicinePharmacologyPathology	1982	234
Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study Armando Santoro, Henning Bredenfeld, Liliana Devizzi, Journal of Clinical Oncology	2000	228
Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease Armando Santoro, Gianni Bonadonna, V. Bonfante, New England Journal of Medicine	1982	213
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. V. Bonfante, Armando Santoro, Simonetta Viviani, Journal of Clinical Oncology	1997	182
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results. Simonetta Viviani, G Bonadonna, A Santoro, Journal of Clinical Oncology	1996	170
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens George Z. Rassidakis, L. Jeffrey Medeiros, Theodoros P. Vassilakopoulos, Blood	2002	101

Page 1